21. Assessment of renal function from creatinine clearance measurement and 131I-hippuran renography in cancer patients before chemotherapyBorut Štabuc, Tine Hajdinjak, Tomaž Edvard Cizej, 1999, izvirni znanstveni članek Povzetek: Background. Serum creatinine and endogenous creatinine clearance (CrCl) are widely used measures of renal function before prescribing nephrotoxic chemotherapy. This study compares the precision and bias in glomerular filtration rate (GFR) estimation without the need to collect urine by using Cockcroft-Gault formula on a single serum creatinine concentration (CrCo) and 131I- hippuran clearance (HC) determined from the renographic curves. Patientsand methods. Fourty-seven patients aged between 27 and 73 years were studied. In all patients, we determined serum creatinine concentration, CrCl, CrCo and HC simultaneously before treatment by combined chemotherapy with cisplatin (CDDP) and in 31 patients, before the third cycle. Serum and urine creatinine concentrations were determined with a Hitachi 911, an automated biochemical analyser CrCl was calculated from the urine flow, from the ratio between the serum and urine creatinine concentrations and was standardized forthe body surface area. Serum creatinine was used to estimate CrCo using a Cockcroft and Gault formula. HC was determined from 131I-hippuran uptake by both kidneys, results were compared to our Nuclear Medicine Department normal values with regard to the age of each patient. For the evaluation of results, Pearson's correlation coefficient and t-test with 95 % confidence interval were used. Results. The sensitivity of serum creatinine, CrCo and HC to predict CrCl<78 mL/min/1.73m2 was 41 %, 68% and 46% and specificity was 95%, 71 % and 76% respectively. Value of CoCr for prediction of reduced CrCl (sensitivity) was statistically significantly better than the HC (p=0.03). Value of CoCr fnr prediction of normal CrCl (specificity) was as good as HC (p=0.3). Conclusions. CrCl for the GFR estimation in the patients treated withnephrotoxic chemotherapy cannot be changed by CrCo and/or HC.
Objavljeno v DiRROS: 22.01.2024; Ogledov: 172; Prenosov: 43
 Celotno besedilo (463,87 KB) |
22. Phase II study of fluorouracil, leucovorin and interferon alpha-2a in patients with advanced colon cancerBorut Štabuc, Aleksandra Markovič, Erik Brecelj, Samir Bešlija, Tomaž-Edvard Cizej, 1998, izvirni znanstveni članek Povzetek: Based on in viro studies that have demonstrated synergy between fluorouracil (5-FU) and leucovorin (LV) as well as between 5-FU and recombinant alpha-2a interferon (IFN) against colon cancer cell lines a phase II study was carried out to evaluate the toxicity and clinical activity of 5-FU modulated with LV and IFN in patients with metastatic colon cancer. Twenty-two chemotherapy naive patients with measurable metastases of colon cancer have been treated with daily doses of 5-FU 600 mg/m2 in 6-hr intravenous infusion, and of LV 20 mg/m2 intravenously and IFN 6 MU subcutaneously, for 5 days every 4 weeks. Median age was 60 years, median PS (ECOG) was 1 (range 0-2). Liver, soft tissue and lung metastases were found in 12, 5 and 8 patients, respectively. Nineteen patients had a single metastatic site, two double, whereas one had more than two metastatic sites. Patients had 2-9 (mean 5) cycles of treatment.Objective response was observed in 7 patients (32%), and stable disease in 7 patients (32%). Overall median survival was 12.5 months, and for responders 14.4 months. Responses were generally short and median time for progression was 5.5 months. The most frequent adverse reactions were flu-like syndrome (50%), nausea/vomiting (36%), diarhoea (13Č), stomatitis (27%) and leucopenia (13%). This regimen of 5-FU with LV and IFN administration does notappear to be superior to previously published shedules of 5-FU with IFN or 5-FU with LV.
Objavljeno v DiRROS: 19.01.2024; Ogledov: 161; Prenosov: 44
Celotno besedilo (430,62 KB) |
23. |
24. |
25. Electrochemotherapy with bleomycin : The first clinical experience in malignant melanoma patientsZvonimir Rudolf, Borut Štabuc, Maja Čemažar, Damijan Miklavčič, Lojze Vodovnik, Gregor Serša, 1995, izvirni znanstveni članek Ključne besede: melanoma therapy, bleomycin, electric stimulation therapy
Objavljeno v DiRROS: 15.01.2024; Ogledov: 166; Prenosov: 44
Celotno besedilo (418,42 KB) |
26. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in miceMaja Čemažar, Damijan Miklavčič, Lojze Vodovnik, Tomaž Jarm, Zvonimir Rudolf, Borut Štabuc, Tanja Čufer, Gregor Serša, 1995, izvirni znanstveni članek Ključne besede: neoplasmas, experimental therapy, cisplatin, electric stimulation therapy, cell membrane permeability
Objavljeno v DiRROS: 15.01.2024; Ogledov: 156; Prenosov: 44
Celotno besedilo (393,12 KB) |
27. |
28. |
29. |
30. O domorodnosti alpskega kozoroga v SlovenijiAndreja Nève Repe, Elena Bužan, Borut Toškan, Jernej Javornik, Boštjan Pokorny, Andrej Arih, Lars Zver, Maruša Prostor, Miha Krofel, Matija Stergar, Klemen Jerina, Hubert Potočnik, Rok Černe, Aleš Poljanec, 2023, strokovni članek Povzetek: Alpski kozorog (Capra ibex) je alpski endemit. Na območju Slovenije naj bi bila vrsta iztrebljena v drugi polovici 17. stoletja, globalno pa je bila zaradi prelova na robu izumrtja konec 19. stoletja. Preživela je le populacija na širšem območju parka Gran Paradiso na skrajnem zahodu Alp v Italiji. Zaradi naselitev in drugih varstvenih programov sedaj alpski kozorog živi v celotnih Alpah, vključno s Slovenijo. Vendar pri nas njegove populacije nazadujejo in so v zelo slabem stanju, kar je lahko rezultat več dejavnikov. Malo izvornih osebkov ob naselitvah, zgodovinska ozka grla in ločenost kolonij so povzročili parjenje v sorodstvu, kar je slabšalo genetsko stanje populacij in lahko negativno vpliva tudi na demografijo. K številčnemu zmanjševanju vrste so lahko prispevale tudi bolezni. Za dolgoročno ohranitev alpskega kozoroga v Sloveniji so nujni takojšnji aktivni ohranitveni ukrepi, pogoj pa je ustrezna opredelitev izvornosti vrste, saj je (bila) zaradi prejšnjih pomanjkljivih podatkov umeščena med tujerodne. V prispevku na podlagi arheo-zooloških, genetskih in preliminarnih habitatnih analiz utemeljujemo, da je v Sloveniji kozorog domorodna vrsta. V raziskavah smo pokazali, da je vrsta živela na ozemlju zdajšnje Slovenije v poznoantičnem in zgodnje srednjeveškem obdobju. Preliminarno smo določili tudi primernost in povezanost habitata kozoroga v slovenskem alpskem svetu ter nakazali verjetne potrebne ukrepe za ohranitev vrste v Sloveniji.
Ključne besede: Capra ibex, izvornost vrste, programi varstva, Alpe, habitat, genetika
Objavljeno v DiRROS: 09.01.2024; Ogledov: 257; Prenosov: 73
Celotno besedilo (475,48 KB) |
